The top 10 pharma R&D budgets in 2024
M&A recap: Big pharma starts the year mostly avoiding billion-dollar deals
RFK Jr. says HHS will reinstate 20% of reduced workforce after DOGE errors
Trump layoffs begin to erode FDA drug review system
*please scroll down for all the latest news *
